COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 885: Articles 8841-8850  | Next

Protection conferred by vaccine plus previous infection (hybrid immunity) with vaccines of three different platforms during the Omicron variant period in Brazil
Cerqueira-Silva, T., de Araujo Oliveira, V., Paixao, E. S., Florentino, P., Penna, G. O., Pearce, N., Werneck, G. L., Barreto, M. L., Boaventura, V. S., Barral-Netto, M.
10.1101/2022.04.12.22273752 — Posted: 2022-04-13
Effectiveness of the BNT162b vaccine fourth dose in reducing SARS-CoV-2 infection among healthcare workers in Israel, a multi-center cohort study
Cohen, M. J., Oster, Y., Moses, A. E., Spitzer, A., Benenson, S., the Israeli-hospitals 4th vaccine Working Group
10.1101/2022.04.11.22273327 — Posted: 2022-04-13
Correlations between kidney and heart function bioindicators and the expressions of Toll-Like, ACE2, and NRP-1 receptors in COVID-19
Soltan, R. H., Abdallah, M. S., Ali, T. M., Ahmed, A. E. S., Assal, H. H., Elesawy, B. H., Ahmed, O. M.
10.1101/2022.04.08.22273322 — Posted: 2022-04-13
Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual.
Halfmann, P., Minor, N. R., Haddock, L. A., Maddox, R., Moreno, G. K., Braun, K., Baker, D., Riemersma, K., Prasad, A., Alman, K. J., Lambert, M. C., Florek, K., Bateman, A., Westergaard, R., Safdar, N., Andes, D. R., Kawaoka, Y., Fida, M., Yao, J. D., Friedrich, T., O'Connor, D. H.
10.1101/2022.04.11.22272784 — Posted: 2022-04-12
Measures for infection prevention and control of SARS-CoV-2 in Belgian schools between December 2020 and June 2021: a prospective cohort study
Callies, M., Kabouche, I., Desombere, I., Merckx, J., Roelants, M., Vermeulen, M., Duysburgh, E.
10.1101/2022.04.12.22273722 — Posted: 2022-04-12
Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
Curlin, M. E., Bates, T. A., Guzman, G., Schoen, D., McBride, S. K., Carpenter, S. D., Tafesse, F. G.
10.1101/2022.04.11.22273694 — Posted: 2022-04-12
Workplace Infection Prevention Control Measures and Work Engagement During the COVID-19 Pandemic among Japanese Workers: A Prospective Cohort Study
Ikegami, K., Ando, H., Fujino, Y., Eguchi, H., Muramatsu, K., Nagata, T., Tateishi, S., Tsuji, M., Ogami, A., the CORoNaWork project
10.1101/2022.04.11.22273753 — Posted: 2022-04-12
The Brain Reacting to COVID-19: Analysis of the Cerebrospinal Fluid and Serum Proteome, Transcriptome and Inflammatory Proteins
Reinhold, D., Yan, Y., Farztdinov, V., Meisel, C., Sadlowski, H., Kuehn, J., Perschel, F. H., Endres, M., Duezel, E., Vielhaber, S., Guttek, K., Goihl, A., Veno, M., Teegen, B., Stoecker, W., Stubbemann, P., Kurth, F., Sander, L. E., Ralser, M., Otto, C., Streit, S., Jarius, S., Ruprecht, K., Radbruch, H., Kjems, J., Muelleder, M., Heppner, F. L., Koertvelyessy, P.
10.1101/2022.04.10.22273673 — Posted: 2022-04-12
Incidence of Guillain-Barre syndrome following SARS-CoV-2 immunization in Mexico: A nationwide registry of seven COVID-19 vaccines
Garcia-Grimshaw, M., Galnares-Olalde, J., Bello-Chavolla, O. Y., Michel-Chavez, A., Cadena-Fernandez, A., Reyes-Teran, G., Arauz, A., Valdes-Ferrer, S. I.
10.1101/2022.04.11.22273754 — Posted: 2022-04-12
Intensity and longevity of SARS-CoV-2 vaccination response and efficacy of adjusted vaccination schedules in patients with immune-mediated inflammatory disease
Simon, D., Tascilar, K., Fagni, F., Kleyer, A., Kroenke, G., Meder, C., Dietrich, P., Orlemann, T., Moessner, J., Taubmann, J., Yalcin Mutlu, M., Knitza, J., Kemenes, S., Liphardt, A. M., Schoenau, V., Bohr, D., Schuster, L., Hartmann, F., Leppkes, M., Ramming, A., Pachowsky, M., Schuch, F., Ronneberger, M., Kleinert, S., Hueber, A. J., Atreya, R., Berking, C., Sticherling, M., Neurath, M. F., Schett, G.
10.1101/2022.04.11.22273729 — Posted: 2022-04-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).